論文・技術情報追加のお知らせ

①Analysis of death avoidance by concomitant use of prednisone in patients with renal transplant using the Food and Drug Administration Adverse Event Reporting System.

腎移植患者における死亡リスク減少に有効な免疫抑制剤の探索研究

対象DB：FAERS

②Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS).

ALK-TKIと不整脈の関連性調査研究

対象DB：FAERS

③Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system.

ラコサミドによる有害事象発生評価研究

対象DB：FAERS

④A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database.

アスピリンの有害事象調査研究

対象DB：FAERS

⑤Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment.

CAR-T細胞治療の安全性向上のための規制措置評価研究

対象DB：EudraVigilance

⑥The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans.

ラスミジタンの安全性調査研究

対象DB：VigiBase

⑦CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis.

免疫チェックポイント阻害薬と巨細胞性動脈炎との関連性評価研究

対象DB：VigiBase